Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma
Andrew Woerner, Guy E. Johnson
Abstract
Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally. Transarterial yttrium-90 radioembolization is a versatile therapy and plays an important role in the treatment of hepatocellular carcinoma. This review summarizes the establishment of radioembolization in the hepatocellular carcinoma treatment paradigm, treatment considerations across cancer stages, and recent advances in evidence.
Topics & Concepts
Hepatocellular carcinomaMedicineCurative treatmentCarcinomaRadiologyOncologyInternal medicineDiseaseHepatocellular Carcinoma Treatment and PrognosisRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and Mutations